Hunan Hansen Pharmaceutical Co., Ltd. 2025 Annual Financial Report
Hunan Hansen Pharmaceutical Co., Ltd. 2025 financial statements were audited by Zhonghuan Certified Public Accountants (Special General Partnership) and an unqualified audit report was issued on April 24, 2026, with report number Zhonghuan Audit Word (2026) 1100057. The auditor's opinion is that the financial statements are prepared in all material respects in accordance with the Accounting Standards for Business Enterprises, and fairly reflect the consolidated and company's financial position as of December 31, 2025, and the consolidated and company's operating results and cash flows for 2025. The 2025 annual financial report is as follows:
I. Key Financial Indicators Achieved (I) Key Accounting Data
Unit: Ten Thousand Yuan
| Item | 2025 | 2024 | Year-on-Year Change |
|---|---|---|---|
| Total Operating Revenue | 103,875.67 | 100,446.95 | 3.41% |
| Total Profit | 23,860.65 | 25,275.66 | -5.60% |
| Net Profit Attributable to Shareholders of Listed Company | 19,812.04 | 22,024.44 | -10.05% |
| Net Profit Attributable to Shareholders of Listed Company Excluding Non-recurring Gains and Losses | 18,987.91 | 21,115.39 | -10.08% |
| Net Cash Flow from Operating Activities | 24,538.13 | 13,078.38 | 87.62% |